Please login to the form below

Not currently logged in
Email:
Password:

ASCO 2013

This page shows the latest ASCO 2013 news and features for those working in and with pharma, biotech and healthcare.

Have you got the adaptability factor?

Have you got the adaptability factor?

that at ASCO 2013, Tweets were up 300 per cent on 2011, #ASCO13 was trending worldwide and over 16, 000 tweets were posted –using said hash tag – by a mixture of ... founder of Big Eye Dear. 1st August 2013.

Latest news

  • ASCO: Boehringer's nintedanib boosts survival in lung cancer subset ASCO: Boehringer's nintedanib boosts survival in lung cancer subset

    Germany, who was the principal investigator in the trial and presented the data at ASCO. ... Meanwhile, a combination study looking at nintedanib in combination with Lilly's Alimta (pemetrexed) in non-squamous NSCLC, called LUME-Lung 2, was also

  • ASCO: Amgen says viral therapy for melanoma ASCO: Amgen says viral therapy for melanoma "encouraging"

    The results of the OPTiM study – reported at the American Society of Clinical Oncology (ASCO) meeting in Chicago – are a milestone as they represent the first time that a virus-based ... data at ASCO. Amgen said it is carrying out early-stage

  • ASCO: Merck and BMS trumpet melanoma trials ASCO: Merck and BMS trumpet melanoma trials

    at the American Society of Clinical Oncology (ASCO) conference in Chicago, US,  over the weekend as optimism builds for the new drug class. ... The NEJM published another study (also presented at ASCO) in which nivolumab was combined with Yervoy to

  • Late-stage failure for Merck’s cilengitide in brain cancer Late-stage failure for Merck’s cilengitide in brain cancer

    Merck said detailed trial results will be submitted for presentation at the American Society of Clinical Oncology (ASCO) 2013 Annual Meeting and publication in a peer-reviewed journal. ... 25th February 2013.

More from news
Approximately 3 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
M3 (EU)

M3 was founded in 2000 with the goal of changing the world of medicine through making full use of the...

Latest intelligence

Unlocking the potential of science and technology in the UK
Greater collaboration is vital in post-Brexit UK, says Alderley Park leader...
NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...

Infographics